Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Atypical Memory B Cells Increase in the Peripheral Blood of Patients With Breast Cancer Regardless of Lymph Node Involvement Publisher Pubmed



Azizi A1 ; Mehdipour F2 ; Samadi M3 ; Rasolmali R4 ; Talei AR5 ; Ghaderi A2, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  2. 2. Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Pathology, Shiraz Central Hospital, Shiraz, Iran
  5. 5. Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Source: BMC Immunology Published:2024


Abstract

Background: Breast cancer is the most common cancer in females. The immune system has a crucial role in the fight against cancer. B and T cells, the two main components of the adaptive immunity, are critical players that specifically target tumor cells. However, B cells, in contrast to T cells, and their role in cancer inhibition or progression is less investigated. Accordingly, in this study, we assessed and compared the frequency of naive and different subsets of memory B cells in the peripheral blood of patients with breast cancer and healthy women. Results: We found no significant differences in the frequencies of peripheral CD19+ B cells between the patients and controls. However, there was a significant decrease in the frequency of CD19+IgM+ B cells in patients compared to the control group (P=0.030). Moreover, the patients exhibited higher percentages of atypical memory B cells (CD19+CD27‒IgM‒, P=0.006) and a non-significant increasing trend in switched memory B cells (CD19+CD27+IgM‒, P=0.074). Further analysis revealed a higher frequency of atypical memory B cells (aMBCs) in the peripheral blood of patients without lymph node involvement as well as those with a tumor size greater than 2cm or with estrogen receptor (ER) negative/progesterone receptor (PR) negative tumors, compared with controls (P=0.030, P=0.040, P=0.031 and P=0.054, respectively). Conclusion: Atypical memory B cells (CD19+CD27‒IgM‒) showed a significant increase in the peripheral blood of patients with breast cancer compared to the control group. This increase seems to be associated with tumor characteristics. Nevertheless, additional research is necessary to determine the precise role of these cells during breast cancer progression © The Author(s) 2024.